Td Asset Management Inc Insmed Inc Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

A detailed history of Td Asset Management Inc transactions in Insmed Inc stock. As of the latest transaction made, Td Asset Management Inc holds 513,082 shares of INSM stock, worth $40.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

513,082

Previous 525,682 2.4%

Holding current value

$40.3 Million

Previous $35.2 Million 6.34%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$62.0 - $79.01 $781,200 - $995,526	-12,600 Reduced 2.4%	513,082 $37.5 Million
Q2 2024 Aug 02, 2024	BUY	$22.0 - $69.71 $2.17 Million - $6.87 Million	98,504 Added 23.06%	525,682 $35.2 Million
Q1 2024 May 08, 2024	SELL	$25.72 - $29.94 $935,024 - $1.09 Million	-36,354 Reduced 7.84%	427,178 $11.6 Million
Q4 2023 Feb 12, 2024	SELL	$23.42 - $31.74 $1.4 Million - $1.89 Million	-59,600 Reduced 11.39%	463,532 $14.4 Million
Q3 2023 Oct 27, 2023	BUY	$19.86 - $26.93 $3.86 Million - $5.23 Million	194,145 Added 59.01%	523,132 $13.2 Million
Q2 2023 Aug 09, 2023	SELL	$16.44 - $21.1 $261,889 - $336,123	-15,930 Reduced 4.62%	328,987 $6.94 Million
Q1 2023 May 10, 2023	SELL	$16.26 - $21.73 $53,056 - $70,904	-3,263 Reduced 0.94%	344,917 $5.88 Million
Q4 2022 Feb 06, 2023	BUY	$16.98 - $23.15 $47,730 - $65,074	2,811 Added 0.81%	348,180 $6.96 Million
Q3 2022 Nov 07, 2022	SELL	$20.88 - $28.21 $138,643 - $187,314	-6,640 Reduced 1.89%	345,369 $7.55 Million
Q2 2022 Aug 04, 2022	SELL	$17.07 - $25.71 $84,957 - $127,958	-4,977 Reduced 1.39%	352,009 $6.94 Million
Q1 2022 May 10, 2022	SELL	$20.42 - $28.13 $652,949 - $899,484	-31,976 Reduced 8.22%	356,986 $8.39 Million
Q4 2021 Feb 10, 2022	BUY	$25.89 - $33.45 $2.96 Million - $3.82 Million	114,230 Added 41.58%	388,962 $10.6 Million
Q3 2021 Nov 09, 2021	SELL	$22.46 - $29.47 $123,440 - $161,967	-5,496 Reduced 1.96%	274,732 $7.57 Million
Q2 2021 Aug 11, 2021	BUY	$24.17 - $36.01 $709,727 - $1.06 Million	29,364 Added 11.71%	280,228 $6.89 Million
Q1 2021 May 14, 2021	BUY	$32.28 - $44.3 $1.7 Million - $2.33 Million	52,626 Added 26.55%	250,864 $8.54 Million
Q4 2020 Feb 16, 2021	BUY	$31.45 - $40.54 $541,443 - $697,936	17,216 Added 9.51%	198,238 $6.6 Million
Q3 2020 Nov 10, 2020	SELL	$26.0 - $34.5 $78,000 - $103,500	-3,000 Reduced 1.63%	181,022 $5.82 Million
Q2 2020 Aug 13, 2020	BUY	$14.11 - $29.42 $988,080 - $2.06 Million	70,027 Added 61.43%	184,022 $5.07 Million
Q1 2020 May 15, 2020	BUY	$13.63 - $33.98 $44,979 - $112,133	3,300 Added 2.98%	113,995 $1.83 Million
Q4 2019 Feb 11, 2020	SELL	$16.12 - $24.98 $175,708 - $272,282	-10,900 Reduced 8.96%	110,695 $2.64 Million
Q3 2019 Nov 07, 2019	SELL	$15.49 - $25.78 $89,082 - $148,260	-5,751 Reduced 4.52%	121,595 $2.15 Million
Q2 2019 Aug 01, 2019	SELL	$23.0 - $32.19 $749,800 - $1.05 Million	-32,600 Reduced 20.38%	127,346 $3.26 Million
Q1 2019 May 08, 2019	SELL	$13.91 - $31.15 $304,629 - $682,185	-21,900 Reduced 12.04%	159,946 $4.65 Million
Q4 2018 Feb 01, 2019	SELL	$11.6 - $18.7 $646,120 - $1.04 Million	-55,700 Reduced 23.45%	181,846 $2.39 Million
Q3 2018 Nov 01, 2018	SELL	$18.95 - $28.08 $533,423 - $790,423	-28,149 Reduced 10.59%	237,546 $4.8 Million
Q2 2018 Jul 31, 2018	BUY	$20.0 - $29.72 $116,000 - $172,376	5,800 Added 2.23%	265,695 $6.28 Million
Q1 2018 May 11, 2018	SELL	$21.69 - $32.99 $19,521 - $29,691	-900 Reduced 0.35%	259,895 $5.85 Million
Q4 2017 Feb 02, 2018	SELL	$26.43 - $31.78 $2,643 - $3,178	-100 Reduced 0.04%	260,795 $8.13 Million
Q3 2017 Nov 09, 2017	BUY	$11.61 - $31.21 $3.03 Million - $8.14 Million	260,895	260,895 $8.14 Million

Others Institutions Holding INSM

# of Institutions

477

Shares Held

180M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.6B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Insmed Inc Transaction History